MARKET

OCX

OCX

ONCOCYTE
AMEX

Real-time Quotes | Nasdaq Last Sale

1.660
+0.050
+3.11%
After Hours: 1.660 0 0.00% 16:00 11/15 EST
OPEN
1.650
PREV CLOSE
1.610
HIGH
1.720
LOW
1.633
VOLUME
308.15K
TURNOVER
--
52 WEEK HIGH
6.92
52 WEEK LOW
1.165
MARKET CAP
62.78M
P/E (TTM)
-4.4768
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OCX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OCX News

  • OncoCyte Corporation (OCX) CEO Ronald Andrews on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.1d ago
  • OncoCyte Corporation Common Stock Q3 EPS $(0.10) Misses $(0.09) Estimate
  • Benzinga.2d ago
  • OncoCyte Provides Corporate Update and Reports Third Quarter 2019 Financial Results
  • GlobeNewswire.2d ago
  • The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
  • Benzinga.2d ago

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About OCX

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.
More

Webull offers OncoCyte Corp (OCX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.